T. Clark Gamblin
No Rating Available
(Learn About Our Rating System)

T. Clark Gamblin, MD, MS, MBA, FACS

Languages spoken: English

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

1950 Circle of Hope
Salt Lake City , UT 84112
801-585-6911
Get Directions

T. Clark Gamblin, MD, MS, MBA, FACS, is a surgical oncologist specializing in complex gastrointestinal (GI) cancers, with expertise in liver, biliary, pancreas, gastric, sarcoma, and peritoneal-based malignancies. He is nationally recognized for leading regional therapies for advanced cancer and pioneering surgical approaches for liver cancer. Dr. Gamblin currently serves as the Chief of the Division of Surgical Oncology at the University of Utah at the Huntsman Cancer Institute.

Clinical Expertise

Dr. Gamblin’s practice focuses on:

  • GI Surgical Oncology

  • Liver Surgery (including benign liver tumors and biliary reconstruction)

  • Biliary and Gallbladder Surgery and Benign Biliary Disease

  • Pancreatic Surgery

  • Gastric (Stomach) Cancer Surgery

  • Sarcoma Surgery

  • Cytoreductive Surgery with HIPEC (Hyperthermic Intraperitoneal Chemotherapy)

  • Neuroendocrine Cancer

  • Laparoscopic and Robotic Surgical Oncology

Education and Training

Dr. Gamblin earned his medical degree at the University of Mississippi Medical Center and completed General Surgery training at Mercer University. He then pursued a Surgical Oncology fellowship at the University of Pittsburgh, where he also earned a Master of Science in Clinical Research, led liver cancer clinical trials, and directed the Neuroendocrine Cancer Program.

Following his fellowship, Dr. Gamblin joined the Medical College of Wisconsin (MCW) as the inaugural Chief of Surgical Oncology, where he built and expanded programs in complex surgical oncology and grew the division to a national leader. While at MCW, he also completed an MBA at the Kellogg School of Management, Northwestern University.

Patient Care Philosophy

Dr. Gamblin believes in partnering with patients and families to educate, guide, and optimize care. He works with a multidisciplinary team to provide thoughtfully aggressive treatments, aiming to eradicate cancer while treating patients with the highest level of respect and compassion.

Research

Dr. Gamblin’s research focuses on outcomes in liver and peritoneal-based malignancies, with a particular emphasis on therapies for advanced cancers and improving patient quality of life. He is focused on hepatobiliary disease presentation, management and optimal outcomes using institutional and large datasets. He is also interested in providing state-of-the- art clinic trials and defining care for the tomorrow's patients.

Personal Interests

Outside of medicine, Dr. Gamblin is an avid runner, reader, camper, and outdoorsman, enjoying time in nature and staying active with his wife and dog Ruby.

Specialties

T. Clark Gamblin, MD, MS, MBA, FACS, is a surgical oncologist specializing in complex gastrointestinal (GI) cancers, with expertise in liver, biliary, pancreas, gastric, sarcoma, and peritoneal-based malignancies. He is nationally recognized for leading regional therapies for advanced cancer and pioneering surgical approaches for liver cancer. Dr. Gamblin currently serves as the Chief of the Division of Surgical Oncology at the University of Utah at the Huntsman Cancer Institute.

Clinical Expertise

Dr. Gamblin’s practice focuses on:

  • GI Surgical Oncology

  • Liver Surgery (including benign liver tumors and biliary reconstruction)

  • Biliary and Gallbladder Surgery and Benign Biliary Disease

  • Pancreatic Surgery

  • Gastric (Stomach) Cancer Surgery

  • Sarcoma Surgery

  • Cytoreductive Surgery with HIPEC (Hyperthermic Intraperitoneal Chemotherapy)

  • Neuroendocrine Cancer

  • Laparoscopic and Robotic Surgical Oncology

Education and Training

Dr. Gamblin earned his medical degree at the University of Mississippi Medical Center and completed General Surgery training at Mercer University. He then pursued a Surgical Oncology fellowship at the University of Pittsburgh, where he also earned a Master of Science in Clinical Research, led liver cancer clinical trials, and directed the Neuroendocrine Cancer Program.

Following his fellowship, Dr. Gamblin joined the Medical College of Wisconsin (MCW) as the inaugural Chief of Surgical Oncology, where he built and expanded programs in complex surgical oncology and grew the division to a national leader. While at MCW, he also completed an MBA at the Kellogg School of Management, Northwestern University.

Patient Care Philosophy

Dr. Gamblin believes in partnering with patients and families to educate, guide, and optimize care. He works with a multidisciplinary team to provide thoughtfully aggressive treatments, aiming to eradicate cancer while treating patients with the highest level of respect and compassion.

Research

Dr. Gamblin’s research focuses on outcomes in liver and peritoneal-based malignancies, with a particular emphasis on therapies for advanced cancers and improving patient quality of life. He is focused on hepatobiliary disease presentation, management and optimal outcomes using institutional and large datasets. He is also interested in providing state-of-the- art clinic trials and defining care for the tomorrow's patients.

Personal Interests

Outside of medicine, Dr. Gamblin is an avid runner, reader, camper, and outdoorsman, enjoying time in nature and staying active with his wife and dog Ruby.

Board Certification and Academic Information

Academic Departments Surgery -Professor
Academic Divisions Surgical Oncology

Education history

Undergraduate Mississippi State University B.S.
Professional Medical Medicine - University of Mississippi School of Medicine M.D.
Residency General Surgery - Mercer University School of Medicine Resident
Fellowship Surgical Oncology - University of Pittsburgh School of Medicine Fellow
Graduate Training University of Pittsburgh M.S.
Graduate Training Northwestern University Kellogg School of Management M.B.A.

Selected Publications

Journal Article

  1. Lyew MA, Gamblin TC, Ayoub M (2000). Systemic anaphylaxis associated with intramammary isosulfan blue injection used for sentinel node detection under general anesthesia. Anesthesiology, 93(4), 1145-6.
  2. Gabriel SA, McDaniel B, Ashley DW, Dalton ML, Gamblin TC (2001). Magnetically guided nasoenteral feeding tubes: a new technique. Am Surg, 67(6), 544-8; discussion 548-9.
  3. Ashley DW, Gamblin TC, Burch ST, Solis MM (2001). Accurate deployment of vena cava filters: comparison of intravascular ultrasound and contrast venography. J Trauma, 50(6), 975-81.
  4. Zunzunegui RG, Werner AM, Gamblin TC, Stephens JL, Ashley DW (2002). Colorectal blowout from compressed air: case report. J Trauma, 52(4), 793-5.
  5. Gamblin TC, Farmer LA, Dean RJ, Bradley RA, Dalton ML (2002). Tracheal polyp. Ann Thorac Surg, 73(4), 1286-7.
  6. Gamblin TC, Dalton ML (2002). Flail chest caused by penetrating trauma: a case report. Curr Surg, 59(4), 418-9.
  7. Lane JE, Gamblin TC, Solis M, Barron T (2002). Laparoscopic orchiectomy for unilateral intra-abdominal testis. Curr Surg, 59(3), 333-5.
  8. Gamblin TC, McKinney WB, Stephens RE Jr, Barron T (2002). Perineuroma of the scrotum. Urology, 60(3), 515.
  9. Gamblin TC, Ashley DW, Burch S, Solis M (2003). A prospective evaluation of a bedside technique for placement of inferior vena cava filters: accuracy and limitations of intravascular ultrasound. Am Surg, 69(5), 382-6.
  10. Gamblin TC, Jennings GR, Christie DB 3rd, Thompson WM Jr, Dalton ML (2003). Ectopic thyroid. Ann Thorac Surg, 75(6), 1952-3.
  11. Gamblin TC, Dalton ML, Morgan JH 3rd, Christie DB 3rd, Vogel RL, Dale PS (2004). Impact of a surgical oncologist on general surgery residency training program. Am J Surg, 187(1), 73-5.
  12. Young HE, Duplaa C, Yost MJ, Henson NL, Floyd JA, Detmer K, Thompson AJ, Powell SW, Gamblin TC, Kizziah K, Holland BJ, Boev A, Van De Water JM, Godbee DC, Jackson S, Rimando M, Edwards CR, Wu E, Cawley C, Edwards PD, Macgregor A, Bozof R, Thompson TM, Petro GJ Jr, Shelton HM, McCampbell BL, Mills JC, Flynt FL, Steele TA, Kearney M, Kirincich-Greathead A, Hardy W, Young PR, Amin AV, Williams RS, Horton MM, McGuinn S, Hawkins KC, Ericson K, Terracio L, Moreau C, Hixson D, Tobin BW, Hudson J, Bowyer FP 3rd, Black AC Jr (2004). Clonogenic analysis reveals reserve stem cells in postnatal mammals. II. Pluripotent epiblastic-like stem cells. Anat Rec A Discov Mol Cell Evol Biol, 277(1), 178-203.
  13. Morgan JH 3rd, Gamblin TC, Adkins JR, Groves JR, Dalton ML, Ashley DW (2004). Norepinephrine is a more potent inhibitor of tumor necrosis factor over a range of doses than dopamine. Am Surg, 70(6), 526-8.
  14. Ashley DW, Gamblin TC, McCampbell BL, Kitchens DM, Dalton ML Jr, Solis MM (2004). Bedside insertion of vena cava filters in the intensive care unit using intravascular ultrasound to locate renal veins. J Trauma, 57(1), 26-31.
  15. Gamblin TC, Wall CE Jr, Morgan JH 3rd, Erickson DJ, Dalton ML, Ashley DW (2004). The natural history of untreated penetrating diaphragm injury: an animal model. J Trauma, 57(5), 989-92.
  16. Morgan JH 3rd, Royer GM, Hackett P, Gamblin TC, McCampbell BL, Conforti A, Dale PS (2004). Radio-frequency ablation of large, nonresectable hepatic tumors. Am Surg, 70(12), 1035-8.
  17. Gamblin TC, Nobles-James C, Bradley RA, Katner HP, Dale PS (2005). Cat scratch disease presenting as breast mastitis. Can J Surg, 48(3), 254-5.
  18. Gamblin TC, Finkelstein SD, Upsal N, Kaye JD, Blumberg D (2006). Microdissection-based allelotyping: a novel technique to determine the temporal sequence and biological aggressiveness of colorectal cancer. Am Surg, 72(5), 445-53.
  19. Koffron A, Geller D, Gamblin TC, Abecassis M (2006). Laparoscopic liver surgery: Shifting the management of liver tumors. Hepatology, 44(6), 1694-700.
  20. Gamblin TC, Edington H, Kirkwood JM, Rao UN (2006). Sentinel lymph node biopsy for atypical melanocytic lesions with spitzoid features. Ann Surg Oncol, 13(12), 1664-70.
  21. Tublin ME, Moser AJ, Marsh JW, Gamblin TC (2007). Biliary inflammatory pseudotumor: imaging features in seven patients. AJR Am J Roentgenol, 188(1), W44-8.
  22. Steel JL, Geller DA, Gamblin TC, Olek MC, Carr BI (2007). Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol, 25(17), 2397-405.
  23. Adkins JR, Gamblin TC, Christie DB, Collings C, Dalton ML, Dale PS (2007). Mammography as screening for coronary artery disease. Am Surg, 73(7), 717-21.
  24. Balaa FK, Gamblin TC, Tsung A, Marsh JW, Geller DA (2008). Right hepatic lobectomy using the staple technique in 101 patients. J Gastrointest Surg, 12(2), 338-43.
  25. Gamblin TC, Egorin MJ, Zuhowski EG, Lagattuta TF, Herscher LL, Russo A, Libutti SK, Alexander HR, Dedrick RL, Bartlett DL (2008). Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas. Cancer Chemother Pharmacol, 62(4), 647-53.
  26. Cho SW, Marsh JW, Fontes PA, Daily MF, Nalesnik M, Tublin M, De Vera ME, Geller DA, Gamblin TC (2008). Extrahepatic portal vein aneurysm--report of six patients and review of the literature. J Gastrointest Surg, 12(1), 145-52.
  27. Gusani NJ, Balaa FK, Steel JL, Geller DA, Marsh JW, Zajko AB, Carr BI, Gamblin TC (2008). Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience. J Gastrointest Surg, 12(1), 129-37.
  28. Li R, Walvekar RR, Nalesnik MA, Gamblin TC (2008). Unresectable hepatocellular carcinoma with a solitary metastasis to the mandible. Am Surg, 74(4), 346-9.
  29. Steel JL, Gamblin TC, Carr BI (2008). Measuring post-traumatic growth in people diagnosed with hepatobiliary cancer: directions for future research. Oncol Nurs Forum, 35(4), 643-50.
  30. Gamblin TC, Holloway SE, Heckman JT, Geller DA (2008). Laparoscopic resection of benign hepatic cysts: a new standard. J Am Coll Surg, 207(5), 731-6.
  31. Cho SW, Marsh JW, Steel J, Holloway SE, Heckman JT, Ochoa ER, Geller DA, Gamblin T (2008). Surgical management of hepatocellular adenoma: take it or leave it?. Annals of surgical oncology, 15(10), 2795-803.
  32. Heckman JT, Devera MB, Marsh JW, Fontes P, Amesur NB, Holloway SE, Nalesnik M, Geller DA, Steel JL, Gamblin T (2008). Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Annals of surgical oncology, 15(11), 3169-77.
  33. Cho SW, Marsh JW, Geller DA, Holtzman M, Zeh H 3rd, Bartlett DL, Gamblin T (2008). Surgical management of leiomyosarcoma of the inferior vena cava. Journal of gastrointestinal surgery, 12(12), 2141-8.
  34. Odoux C, Fohrer H, Hoppo T, Guzik L, Stolz DB, Lewis DW, Gollin SM, Gamblin TC, Geller DA, Lagasse (2008). A stochastic model for cancer stem cell origin in metastatic colon cancer. Cancer research, 68(17), 6932-41.
  35. Bark K, Gamblin TC, Zuckerman R, Geller D (2009). Operative choledochoscopic laser lithotripsy for impacted intrahepatic gallstones: a novel surgical approach. Surgical endoscopy, 23(1), 221-4.
  36. Gamblin TC, Krasinskas AM, Slivka AS, Tublin ME, Demetris J, Shue E, Caro S, Marsh JW, James Moser (2009). Fibroinflammatory biliary stricture: a rare bile duct lesion masquerading as cholangiocarcinoma. Journal of gastrointestinal surgery, 13(4), 713-21.
  37. Dhupar R, de Vera ME, Marsh JW, Fontes PA, Steel JL, Zeh HJ, Gamblin T (2009). Simultaneous pancreatectomy and liver transplantation: a single-institution experience. HPB, 11(3), 242-6.
  38. Nguyen KT, Laurent A, Dagher I, Geller DA, Steel J, Thomas MT, Marvin M, Ravindra KV, Mejia A, Lainas P, Franco D, Cherqui D, Buell JF, Gamblin T (2009). Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes. Annals of surgery, 250(5), 842-8.
  39. Dagher I, O'Rourke N, Geller DA, Cherqui D, Belli G, Gamblin TC, Lainas P, Laurent A, Nguyen KT, Marvin MR, Thomas M, Ravindra K, Fielding G, Franco D, Buell J (2009). Laparoscopic major hepatectomy: an evolution in standard of care. Annals of surgery, 250(5), 856-60.
  40. Nguyen KT, Steel J, Vanounou T, Tsung A, Marsh JW, Geller DA, Gamblin T (2009). Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection?. Annals of surgical oncology, 16(12), 3308-15.
  41. Dhupar R, Gulack B, Geller DA, Marsh JW, Gamblin T (2009). The changing presentation of choledochal cyst disease: an incidental diagnosis. HPB surgery, 2009, 103739.
  42. Buell JF, Cherqui D, Geller DA, O'Rourke N, Iannitti D, Dagher I, Koffron AJ, Thomas M, Gayet B, Han HS, Wakabayashi G, Belli G, Kaneko H, Ker CG, Scatton O, Laurent A, Abdalla EK, Chaudhury P, Dutson E, Gamblin C, D'Angelica M, Nagorney D, Testa G, Labow D, Manas D, Poon RT, Nelson H, Martin R, Clary B, Pinson WC, Martinie J, Vauthey JN, Goldstein R, Roayaie S, Barlet D, Espat J, Abecassis M, Rees M, Fong Y, McMasters KM, Broelsch C, Busuttil R, Belghiti J, Strasberg S, Chari RS, World Consensus Conference on Laparoscopic Surger (2009). The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Annals of surgery, 250(5), 825-30.
  43. Cardinal J, de Vera ME, Marsh JW, Steel JL, Geller DA, Fontes P, Nalesnik M, Gamblin T (2009). Treatment of hepatic epithelioid hemangioendothelioma: a single-institution experience with 25 cases. Archives of surgery (Chicago, Ill., 144(11), 1035-9.
  44. Vanounou T, Steel JL, Nguyen KT, Tsung A, Marsh JW, Geller DA, Gamblin T (2010). Comparing the clinical and economic impact of laparoscopic versus open liver resection. Annals of surgical oncology, 17(4), 998-1009.
  45. Steel JL, Kim KH, Dew MA, Unruh ML, Antoni MH, Olek MC, Geller DA, Carr BI, Butterfield LH, Gamblin T (2010). Cancer-related symptom clusters, eosinophils, and survival in hepatobiliary cancer: an exploratory study. Journal of pain and symptom management, 39(5), 859-71.
  46. Cho SW, Kitisin K, Buck D, Steel J, Brufsky A, Gillespie R, Tsung A, Marsh JW, Geller DA, Gamblin T (2010). Transcatheter arterial chemoembolization is a feasible palliative locoregional therapy for breast cancer liver metastases. International journal of surgical oncology, 2010, 251621.
  47. Mayo SC, de Jong MC, Pulitano C, Clary BM, Reddy SK, Gamblin TC, Celinksi SA, Kooby DA, Staley CA, Stokes JB, Chu CK, Ferrero A, Schulick RD, Choti MA, Mentha G, Strub J, Bauer TW, Adams RB, Aldrighetti L, Capussotti L, Pawlik T (2010). Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Annals of surgical oncology, 17(12), 3129-36.
  48. Cho SW, Steel J, Tsung A, Marsh JW, Geller DA, Gamblin T (2011). Safety of liver resection in the elderly: how important is age?. Annals of surgical oncology, 18(4), 1088-95.
  49. Nguyen KT, Kitisin K, Steel J, Jeyabalan G, Aggarwal S, Geller DA, Gamblin T (2011). Cirrhosis is not a contraindication to laparoscopic cholecystectomy: results and practical recommendations. HPB, 13(3), 192-7.
  50. Reddy SK, Barbas AS, Turley RS, Gamblin TC, Geller DA, Marsh JW, Tsung A, Clary BM, Lagoo-Deenadayalan (2011). Major liver resection in elderly patients: a multi-institutional analysis. Journal of the American College of Surgeons, 212(5), 787-95.
  51. Moore AM, Gamblin TC, Geller DA, Youssef MN, Hoffman KE, Gemmell L, Likumahuwa SM, Bovbjerg DH, Marsland A, Steel J (2011). A prospective study of posttraumatic growth as assessed by self-report and family caregiver in the context of advanced cancer. Psycho-oncology, 20(5), 479-87.
  52. Steel J, Geller DA, Tsung A, Marsh JW, Dew MA, Spring M, Grady J, Likumahuwa S, Dunlavy A, Youssef M, Antoni M, Butterfield LH, Schulz R, Day R, Helgeson V, Kim KH, Gamblin T (2011). Randomized controlled trial of a collaborative care intervention to manage cancer-related symptoms: lessons learned. Clinical trials (London, England), 8(3), 298-310.
  53. Nace GW, Steel JL, Amesur N, Zajko A, Nastasi BE, Joyce J, Sheetz M, Gamblin T (2011). Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experience. International journal of surgical oncology, 2011, 571261.
  54. de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L, Ferrone CR, Zhu AX, Bauer TW, Walters DM, Gamblin TC, Nguyen KT, Turley R, Popescu I, Hubert C, Meyer S, Schulick RD, Choti MA, Gigot JF, Mentha G, Pawlik T (2011). Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. Journal of clinical oncology, 29(23), 3140-5.
  55. Kitisin K, Packiam V, Steel J, Humar A, Gamblin TC, Geller DA, Marsh JW, Tsung (2011). Presentation and outcomes of hepatocellular carcinoma patients at a western centre. HPB, 13(10), 712-22.
  56. Mayo SC, de Jong MC, Bloomston M, Pulitano C, Clary BM, Reddy SK, Clark Gamblin T, Celinski SA, Kooby DA, Staley CA, Stokes JB, Chu CK, Arrese D, Ferrero A, Schulick RD, Choti MA, Geschwind JF, Strub J, Bauer TW, Adams RB, Aldrighetti L, Mentha G, Capussotti L, Pawlik T (2011). Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. Annals of surgical oncology, 18(13), 3657-65.
  57. Vanounou T, Groeschl RT, Geller DA, Marsh JW, Gamblin T (2012). Economic model of observation versus immediate resection of hepatic adenomas. Journal of surgical oncology, 106(4), 491-7.
  58. Turaga KK, Pappas SG, Gamblin (2012). Importance of histologic subtype in the staging of appendiceal tumors. Annals of surgical oncology, 19(5), 1379-85.
  59. Groeschl RT, Nachmany I, Steel JL, Reddy SK, Glazer ES, de Jong MC, Pawlik TM, Geller DA, Tsung A, Marsh JW, Clary BM, Curley SA, Gamblin T (2012). Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. Journal of the American College of Surgeons, 214(5), 769-77.
  60. Turaga KK, Gamblin T (2012). Measuring the surgical academic output of an institution: the "institutional" H-index. Journal of surgical education, 69(4), 499-503.
  61. Johnston FM, Kneuertz PJ, Cameron JL, Sanford D, Fisher S, Turley R, Groeschl R, Hyder O, Kooby DA, Blazer D 3rd, Choti MA, Wolfgang CL, Gamblin TC, Hawkins WG, Maithel SK, Pawlik T (2012). Presentation and management of gastrointestinal stromal tumors of the duodenum: a multi-institutional analysis. Annals of surgical oncology, 19(11), 3351-60.
  62. Turaga KK, Gamblin TC, Pappas (2012). Surgical treatment of peritoneal carcinomatosis from gastric cancer. International journal of surgical oncology, 2012, 405652.
  63. Turaga KK, Tsai S, Wiebe LA, Evans DB, Gamblin T (2013). Novel multimodality treatment sequencing for extrahepatic (mid and distal) cholangiocarcinoma. Annals of surgical oncology, 20(4), 1230-9.
  64. Peng PD, Hyder O, Mavros MN, Turley R, Groeschl R, Firoozmand A, Lidsky M, Herman JM, Choti M, Ahuja N, Anders R, Blazer DG 3rd, Gamblin TC, Pawlik T (2012). Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients. Annals of surgical oncology, 19(13), 4036-42.
  65. Groeschl RT, Christians KK, Turaga KK, Gamblin T (2013). Management of primary hepatopancreatobiliary small cell carcinoma. Journal of surgical oncology, 107(7), 692-5.
  66. Groeschl RT, Turaga KK, Gamblin T (2013). Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma. Journal of surgical oncology, 107(6), 608-12.
  67. Groeschl RT, Wong RK, Quebbeman EJ, Tsai S, Turaga KK, Pappas SG, Christians KK, Hohenwalter EJ, Tutton SM, Rilling WS, Gamblin T (2013). Recurrence after microwave ablation of liver malignancies: a single institution experience. HPB, 15(5), 365-71.
  68. Hyder O, Hatzaras I, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L, Ferrone CR, Zhu AX, Bauer TW, Walters DM, Groeschl R, Gamblin TC, Marsh JW, Nguyen KT, Turley R, Popescu I, Hubert C, Meyer S, Choti MA, Gigot JF, Mentha G, Pawlik T (2013). Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery, 153(6), 811-8.
  69. Pappas SG, Christians KK, Tolat PP, Mautz AP, Lal A, McElroy L, Gamblin TC, Turaga KK, Tsai S, Erickson B, Ritch P, Evans D (2014). Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility?. HPB, 16(1), 70-4.
  70. Belli G, Gayet B, Han HS, Wakabayashi G, Kim KH, Cannon R, Kaneko H, Gamblin T, Koffron A, Dagher I, Buell JF, International Consensus Group for Laparoscopic Liver Surger (2013). Laparoscopic left hemihepatectomy a consideration for acceptance as standard of care. Surgical endoscopy, 27(8), 2721-6.
  71. Turaga KK, Pappas S, Gamblin T (2013). Right hemicolectomy for mucinous adenocarcinoma of the appendix: just right or too much?. Annals of surgical oncology, 20(4), 1063-7.
  72. Groeschl RT, Hong JC, Christians KK, Turaga KK, Tsai S, Pilgrim CH, Gamblin T (2013). Viral status at the time of liver transplantation for hepatocellular carcinoma: a modern predictor of longterm survival. HPB, 15(10), 794-802.
  73. Groeschl RT, Gamblin TC, Turaga K (2013). Ablation for hepatocellular carcinoma: validating the 3-cm breakpoint. Annals of surgical oncology, 20(11), 3591-5.
  74. Miura JT, Evans DB, Pappas SG, Gamblin TC, Turaga K (2013). Borderline resectable/locally advanced pancreatic adenocarcinoma: improvements needed in population-based registries. Annals of surgical oncology, 20(13), 4338-47.
  75. Pappas SG, Pilgrim CH, Keim R, Harris R, Wilson S, Turaga K, Tsai S, Dua K, Khan A, Oh Y, Gamblin TC, Christians (2013). The Frey procedure for chronic pancreatitis secondary to pancreas divisum. JAMA surgery, 148(11), 1057-62.
  76. Dilip A, Cheng G, Joseph J, Kunnimalaiyaan S, Kalyanaraman B, Kunnimalaiyaan M, Gamblin T (2013). Mitochondria-targeted antioxidant and glycolysis inhibition: synergistic therapy in hepatocellular carcinoma. Anti-cancer drugs, 24(9), 881-8.
  77. Turaga KK, Green DE, Jayakrishnan TT, Hwang M, Gamblin T (2013). Attributes of a surgical chairperson associated with extramural funding of a department of surgery. The Journal of surgical research, 185(2), 549-54.
  78. Groeschl RT, Clark Gamblin T, Turaga K (2013). Surgical resection in hepatocellular carcinoma patients with minimal background fibrosis: a strategy in the era of organ shortage. Annals of surgical oncology, 20(6), 2043-8.
  79. Groeschl RT, Pilgrim CH, Hanna EM, Simo KA, Swan RZ, Sindram D, Martinie JB, Iannitti DA, Bloomston M, Schmidt C, Khabiri H, Shirley LA, Martin RC, Tsai S, Turaga KK, Christians KK, Rilling WS, Gamblin T (2014). Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Annals of surgery, 259(6), 1195-200.
  80. Wilson JM, Groeschl R, George B, Turaga KK, Patel PJ, Saeian K, Gamblin T (2013). Ciliated hepatic cyst leading to squamous cell carcinoma of the liver - A case report and review of the literature. International journal of surgery case reports, 4(11), 972-5.
  81. Hyder O, Marques H, Pulitano C, Marsh JW, Alexandrescu S, Bauer TW, Gamblin TC, Sotiropoulos GC, Paul A, Barroso E, Clary BM, Aldrighetti L, Ferrone CR, Zhu AX, Popescu I, Gigot JF, Mentha G, Feng S, Pawlik T (2014). A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA surgery, 149(5), 432-8.
  82. Sullivan KM, Groeschl RT, Turaga KK, Tsai S, Christians KK, White SB, Rilling WS, Pilgrim CH, Gamblin T (2014). Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspective. Journal of surgical oncology, 109(2), 95-7.
  83. Carter YM, Kunnimalaiyaan S, Chen H, Gamblin TC, Kunnimalaiyaan (2014). Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth. Cancer biology & therapy, 15(5), 510-5.
  84. Arnaoutakis DJ, Kim Y, Pulitano C, Zaydfudim V, Squires MH, Kooby D, Groeschl R, Alexandrescu S, Bauer TW, Bloomston M, Soares K, Marques H, Gamblin TC, Popescu I, Adams R, Nagorney D, Barroso E, Maithel SK, Crawford M, Sandroussi C, Marsh W, Pawlik T (2015). Management of biliary cystic tumors: a multi-institutional analysis of a rare liver tumor. Annals of surgery, 261(2), 361-7.
  85. Groeschl RT, Miura JT, Oshima K, Gamblin TC, Turaga K (2014). Does histology predict outcome for malignant vascular tumors of the liver?. Journal of surgical oncology, 109(5), 483-6.
  86. Butterfield LH, Economou JS, Gamblin TC, Geller D (2014). Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients. Journal of translational medicine, 12, 86.
  87. Turaga KK, Gamblin T (2014). Regional therapies for advanced cancer. Annals of surgical oncology, 21(5), 1426-8.
  88. Nadeem H, Jayakrishnan TT, Groeschl RT, Zacharias A, Clark Gamblin T, Turaga K (2014). Cost effectiveness of routine laparoscopic ultrasound for assessment of resectability of gallbladder cancer. Annals of surgical oncology, 21(7), 2413-9.
  89. Bischof DA, Kim Y, Dodson R, Carolina Jimenez M, Behman R, Cocieru A, Blazer DG 3rd, Fisher SB, Squires MH 3rd, Kooby DA, Maithel SK, Groeschl RT, Clark Gamblin T, Bauer TW, Karanicolas PJ, Law C, Quereshy FA, Pawlik T (2014). Open versus minimally invasive resection of gastric GIST: a multi-institutional analysis of short- and long-term outcomes. Annals of surgical oncology, 21(9), 2941-8.
  90. Spolverato G, Ejaz A, Kim Y, Sotiropoulos GC, Pau A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L, Bauer TW, Walters DM, Groeschl R, Gamblin TC, Marsh W, Nguyen KT, Turley R, Popescu I, Hubert C, Meyer S, Gigot JF, Mentha G, Pawlik T (2014). Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma. Journal of gastrointestinal surgery, 18(7), 1284-91.
  91. Groeschl RT, Miura JT, Wong RK, Bloomston M, Lidsky ML, Clary BM, Martin RC, Belli G, Buell JF, Gamblin T (2014). Multi-institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinoma. Journal of surgical oncology, 110(4), 412-5.
  92. Miura JT, Johnston FM, Gamblin TC, Turaga K (2014). Current trends in the management of malignant peritoneal mesothelioma. Annals of surgical oncology, 21(12), 3947-53.
  93. Miura JT, Johnston FM, Thomas J, George B, Eastwood D, Tsai S, Christians KK, Turaga KK, Gamblin T (2014). Molecular profiling in gastric cancer: examining potential targets for chemotherapy. Journal of surgical oncology, 110(3), 302-6.
  94. Miura JT, Amini A, Schmocker R, Nichols S, Sukato D, Winslow ER, Spolverato G, Ejaz A, Squires MH, Kooby DA, Maithel SK, Li A, Wu MC, Sarmiento JM, Bloomston M, Christians KK, Johnston FM, Tsai S, Turaga KK, Tsung A, Pawlik TM, Gamblin T (2014). Surgical management of hepatic hemangiomas: a multi-institutional experience. HPB, 16(10), 924-8.
  95. Zhu AX, Borger DR, Kim Y, Cosgrove D, Ejaz A, Alexandrescu S, Groeschl RT, Deshpande V, Lindberg JM, Ferrone C, Sempoux C, Yau T, Poon R, Popescu I, Bauer TW, Gamblin TC, Gigot JF, Anders RA, Pawlik T (2014). Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets. Annals of surgical oncology, 21(12), 3827-34.
  96. Wilson JM, Kunnimalaiyaan S, Gamblin TC, Kunnimalaiyaan (2014). MK2206 inhibits hepatocellular carcinoma cellular proliferation via induction of apoptosis and cell cycle arrest. The Journal of surgical research, 191(2), 280-5.
  97. Jayakrishnan TT, Nadeem H, Groeschl RT, George B, Thomas JP, Ritch PS, Christians KK, Tsai S, Evans DB, Pappas SG, Gamblin TC, Turaga K (2015). Diagnostic laparoscopy should be performed before definitive resection for pancreatic cancer: a financial argument. HPB, 17(2), 131-9.
  98. Bischof DA, Kim Y, Blazer DG 3rd, Behman R, Karanicolas PJ, Law CH, Quereshy FA, Maithel SK, Gamblin TC, Bauer TW, Pawlik T (2014). Surgical management of advanced gastrointestinal stromal tumors: an international multi-institutional analysis of 158 patients. Journal of the American College of Surgeons, 219(3), 439-49.
  99. Jayakrishnan TT, Zacharias AJ, Sharma A, Pappas SG, Gamblin TC, Turaga K (2014). Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). World journal of surgical oncology, 12, 270.
  100. Miura JT, Jayakrishnan TT, Amini A, Johnston FM, Tsai S, Erickson B, Quebbeman EJ, Christians KK, Evans DB, Gamblin TC, Turaga K (2014). Defining the role of adjuvant external beam radiotherapy on resected adenocarcinoma of the ampulla of vater. Journal of gastrointestinal surgery, 18(11), 2003-8.
  101. Jayakrishnan TT, Green DE, Hwang M, Zacharias AJ, Sharma A, Johnston FM, Gamblin TC, Turaga K (2014). Effect of the experience of surgical chairpersons on departmental National Institutes of Health funding. The Journal of surgical research, 192(2), 293-7.
  102. Bischof DA, Kim Y, Behman R, Karanicolas PJ, Quereshy FA, Blazer DG 3rd, Maithel SK, Gamblin TC, Bauer TW, Pawlik T (2014). A nomogram to predict disease-free survival after surgical resection of GIST. Journal of gastrointestinal surgery, 18(12), 2123-9.
  103. Krepline AN, Christians KK, Duelge K, Mahmoud A, Ritch P, George B, Erickson BA, Foley WD, Quebbeman EJ, Turaga KK, Johnston FM, Gamblin TC, Evans DB, Tsai (2014). Patency rates of portal vein/superior mesenteric vein reconstruction after pancreatectomy for pancreatic cancer. Journal of gastrointestinal surgery, 18(11), 2016-25.
  104. Beyer AM, Durand MJ, Hockenberry J, Gamblin TC, Phillips SA, Gutterman D (2014). An acute rise in intraluminal pressure shifts the mediator of flow-mediated dilation from nitric oxide to hydrogen peroxide in human arterioles. American journal of physiology. Heart and circulatory physiology, 307(11), H1587-93.
  105. Nadeem H, Jayakrishnan TT, Groeschl RT, Zacharias A, Clark Gamblin T, Turaga K (2014). Cost effectiveness of routine laparoscopic ultrasound for assessment of resectability of gallbladder cancer. Annals of surgical oncology, 21(7), 2413-9.
  106. Groeschl RT, Riggle KM, Quebbeman EJ, Christians KK, Turaga KK, Tsai S, Gamblin T (2014). Hepatectomy for hemangioma; safe, but is it successful?. Hepato-gastroenterology, 61(135), 2009-13.
  107. Amini A, Miura JT, Jayakrishnan TT, Johnston FM, Tsai S, Christians KK, Gamblin TC, Turaga K (2015). Is local resection adequate for T1 stage ampullary cancer?. HPB, 17(1), 66-71.
  108. Amini A, Gamblin T (2014). Palliation: treating patients with inoperable biliary tract and primary liver tumors. Surgical oncology clinics of North America, 23(2), 383-97.
  109. Ferrone CR, Ting DT, Shahid M, Konstantinidis IT, Sabbatino F, Goyal L, Rice-Stitt T, Mubeen A, Arora K, Bardeesey N, Miura J, Gamblin TC, Zhu AX, Borger D, Lillemoe KD, Rivera MN, Deshpande (2016). The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology. Annals of surgical oncology, 23(1), 290-6.
  110. Margonis GA, Spolverato G, Kim Y, Marques H, Poultsides G, Maithel S, Aldrighetti L, Bauer TW, Jabbour N, Gamblin TC, Soares K, Pawlik T (2015). Minimally invasive resection of choledochal cyst: a feasible and safe surgical option. Journal of gastrointestinal surgery, 19(5), 858-65.
  111. Green DE, Jayakrishnan TT, Hwang M, Pappas SG, Gamblin TC, Turaga K (2015). Immunohistochemistry - microarray analysis of patients with peritoneal metastases of appendiceal or colorectal origin. Frontiers in surgery, 1, 50.
  112. Bischof DA, Dodson R, Jimenez MC, Behman R, Cocieru A, Blazer DG 3rd, Fisher SB, Squires MH 3rd, Kooby DA, Maithel SK, Groeschl RT, Gamblin TC, Bauer TW, Karanicolas PJ, Law C, Quereshy FA, Pawlik T (2015). Adherence to Guidelines for Adjuvant Imatinib Therapy for GIST: A Multi-institutional Analysis. Journal of gastrointestinal surgery, 19(6), 1022-8.
  113. Bischof DA, Kim Y, Dodson R, Jimenez MC, Behman R, Cocieru A, Fisher SB, Groeschl RT, Squires MH 3rd, Maithel SK, Blazer DG 3rd, Kooby DA, Gamblin TC, Bauer TW, Quereshy FA, Karanicolas PJ, Law CH, Pawlik T (2015). Conditional disease-free survival after surgical resection of gastrointestinal stromal tumors: a multi-institutional analysis of 502 patients. JAMA surgery, 150(4), 299-306.
  114. Wilson JM, Kunnimalaiyaan S, Kunnimalaiyaan M, Gamblin T (2015). Inhibition of the AKT pathway in cholangiocarcinoma by MK2206 reduces cellular viability via induction of apoptosis. Cancer cell international, 15(1), 13.
  115. Glenn JA, Turaga KK, Gamblin TC, Hohmann SF, Johnston F (2015). Minimally invasive gastrectomy for cancer: current utilization in US academic medical centers. Surgical endoscopy, 29(12), 3768-75.
  116. Spolverato G, Kim Y, Ejaz A, Alexandrescu S, Marques H, Aldrighetti L, Gamblin TC, Pulitano C, Bauer TW, Shen F, Sandroussi C, Poultsides G, Maithel SK, Pawlik T (2015). Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 535 Patients. JAMA surgery, 150(6), 538-45.
  117. Ferretti S, Tranchart H, Buell JF, Eretta C, Patriti A, Spampinato MG, Huh JW, Vigano L, Han HS, Ettorre GM, Jovine E, Gamblin TC, Belli G, Wakabayashi G, Gayet B, Dagher (2015). Laparoscopic Simultaneous Resection of Colorectal Primary Tumor and Liver Metastases: Results of a Multicenter International Study. World journal of surgery, 39(8), 2052-60.
  118. Miura JT, Xiu J, Thomas J, George B, Carron BR, Tsai S, Johnston FM, Turaga KK, Gamblin T (2015). Tumor profiling of gastric and esophageal carcinoma reveal different treatment options. Cancer biology & therapy, 16(5), 764-9.
  119. Spolverato G, Yakoob MY, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Pawlik T (2015). The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma. Annals of surgical oncology, 22(12), 4020-8.
  120. Kunnimalaiyaan S, Trevino J, Tsai S, Gamblin TC, Kunnimalaiyaan (2015). Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells. Molecular cancer therapeutics, 14(6), 1395-403.
  121. Kunnimalaiyaan S, Sokolowski KM, Balamurugan M, Gamblin TC, Kunnimalaiyaan (2015). Xanthohumol inhibits Notch signaling and induces apoptosis in hepatocellular carcinoma. PloS one, 10(5), e0127464.
  122. Soares KC, Kim Y, Spolverato G, Maithel S, Bauer TW, Marques H, Sobral M, Knoblich M, Tran T, Aldrighetti L, Jabbour N, Poultsides GA, Gamblin TC, Pawlik T (2015). Presentation and Clinical Outcomes of Choledochal Cysts in Children and Adults: A Multi-institutional Analysis. JAMA surgery, 150(6), 577-84.
  123. Spolverato G, Maqsood H, Vitale A, Alexandrescu S, Marques HP, Aldrighetti L, Gamblin TC, Pulitano C, Bauer TW, Shen F, Poultsides G, Maithel S, Marsh JW, Pawlik T (2015). Readmission After Liver Resection for Intrahepatic Cholangiocarcinoma: a Multi-Institutional Analysis. Journal of gastrointestinal surgery, 19(7), 1334-41.
  124. Spolverato G, Yakoob MY, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Pawlik T (2015). Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinoma. Cancer, 121(16), 2730-9.
  125. Kunnimalaiyaan S, Gamblin TC, Kunnimalaiyaan (2015). Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression. HPB, 17(9), 770-6.
  126. Miura JT, Rilling WS, White SB, Hieb RA, Tutton SM, Patel PJ, Gamblin TC, Hohenwalter E (2015). Safety and efficacy of transarterial chemoembolization in patients with transjugular intrahepatic portosystemic shunts. HPB, 17(8), 707-12.
  127. Miura JT, Johnston FM, Tsai S, Eastwood D, Banerjee A, Christians KK, Turaga KK, Gamblin T (2015). Surgical resection versus ablation for hepatocellular carcinoma ¿ 3 cm: a population-based analysis. HPB, 17(10), 896-901.
  128. Miura JT, Charlson J, Gamblin TC, Eastwood D, Banerjee A, Johnston FM, Turaga K (2015). Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma. European journal of surgical oncology, 41(10), 1386-92.
  129. Larrieux G, Wachi BI, Miura JT, Turaga KK, Christians KK, Gamblin TC, Peltier WL, Weissman DE, Nattinger AB, Johnston F (2015). Palliative Care Training in Surgical Oncology and Hepatobiliary Fellowships: A National Survey of Program Directors. Annals of surgical oncology, 22 Suppl 3, S1181-6.
  130. Spolverato G, Vitale A, Cucchetti A, Popescu I, Marques HP, Aldrighetti L, Gamblin TC, Maithel SK, Sandroussi C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Pawlik T (2015). Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma?. Cancer, 121(22), 3998-4006.
  131. Potkonjak M, Miura JT, Turaga KK, Johnston FM, Tsai S, Christians KK, Gamblin T (2015). Intrahepatic cholangiocarcinoma and gallbladder cancer: distinguishing molecular profiles to guide potential therapy. HPB, 17(12), 1119-23.
  132. Zacharias AJ, Jayakrishnan TT, Rajeev R, Rilling WS, Thomas JP, George B, Johnston FM, Gamblin TC, Turaga K (2015). Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-Analysis. PloS one, 10(10), e0139940.
  133. Bagante F, Gani F, Spolverato G, Xu L, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Pawlik T (2015). Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy. Journal of the American College of Surgeons, 221(6), 1031-40.e1-4.
  134. Sokolowski KM, Balamurugan M, Kunnimalaiyaan S, Wilson J, Gamblin TC, Kunnimalaiyaan (2016). Role of Akt inhibition on Notch1 expression in hepatocellular carcinoma: potential role for dual targeted therapy. American journal of surgery, 211(4), 755-60.
  135. Nadeem H, Jayakrishnan TT, Rajeev R, Johnston FM, Gamblin TC, Turaga K (2016). Cost Differential of Chemotherapy for Solid Tumors. Journal of oncology practice, 12(3), e299-307, 251.
  136. Bagante F, Spolverato G, Cucchetti A, Gani F, Popescu I, Ruzzenente A, Marques HP, Aldrighetti L, Gamblin TC, Maithel SK, Sandroussi C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Guglielmi A, Pawlik T (2016). Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: A regret-based decision curves analysis. Surgery, 160(1), 106-117.
  137. Margonis GA, Samaha M, Kim Y, Postlewait LM, Kunz P, Maithel S, Tran T, Berger N, Gamblin TC, Mullen MG, Bauer TW, Pawlik T (2016). A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis. Journal of gastrointestinal surgery, 20(6), 1098-105.
  138. Ang C, Miura JT, Gamblin TC, He R, Xiu J, Millis SZ, Gatalica Z, Reddy SK, Yee NS, Abou-Alfa G (2016). Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options. Journal of surgical oncology, 113(1), 55-61.
  139. Vitale A, Spolverato G, Bagante F, Gani F, Popescu I, Marques HP, Aldrighetti L, Gamblin TC, Maithel SK, Sandroussi C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Pawlik T (2016). A multi-institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinoma. Journal of surgical oncology, 113(4), 420-6.
  140. Klooster B, Rajeev R, Chrabaszcz S, Charlson J, Miura J, Bedi M, Gamblin TC, Johnston F, Turaga K (2016). Is long-term survival possible after margin-positive resection of retroperitoneal sarcoma (RPS)?. Journal of surgical oncology, 113(7), 823-7.
  141. Philips P, Groeschl RT, Hanna EM, Swan RZ, Turaga KK, Martinie JB, Iannitti DA, Schmidt C, Gamblin TC, Martin R (2016). Single-stage resection and microwave ablation for bilobar colorectal liver metastases. The British journal of surgery, 103(8), 1048-54.
  142. Margonis GA, Buettner S, Sasaki K, Kim Y, Ratti F, Russolillo N, Ferrero A, Berger N, Gamblin TC, Poultsides G, Tran T, Postlewait LM, Maithel S, Michaels AD, Bauer TW, Marques H, Barroso E, Aldrighetti L, Pawlik T (2016). The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a multi-institutional analysis. HPB, 18(8), 700-5.
  143. Jayakrishnan TT, Sekigami Y, Rajeev R, Gamblin TC, Turaga K (2017). Morbidity of curative cancer surgery and suicide risk. Psycho-oncology, 26(11), 1792-1798.
  144. Hammad AY, Berger NG, Eastwood D, Tsai S, Turaga KK, Christian KK, Johnston FM, Pawlik TM, Gamblin T (2016). Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival. Annals of surgical oncology, 23(Suppl 5), 912-920.
  145. Buettner S, Koerkamp BG, Ejaz A, Buisman FE, Kim Y, Margonis GA, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Marsh JW, IJzermans JN, Pawlik T (2017). The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients-A multi-institutional analysis. Journal of surgical oncology, 115(3), 312-318.
  146. Hammad AY, Robbins JR, Turaga KK, Christians KK, Gamblin TC, Johnston F (2017). Palliative interventions for hepatocellular carcinoma patients: analysis of the National Cancer Database. Annals of palliative medicine, 6(1), 26-35.
  147. Kunnimalaiyaan S, Sokolowski K, Gamblin TC, Kunnimalaiyaan (2017). Suberoylanilide hydroxamic Acid, a histone deacetylase inhibitor, alters multiple signaling pathways in hepatocellular carcinoma cell lines. American journal of surgery, 213(4), 645-651.
  148. Berger NG, Tanious MN, Hammad AY, Miura JT, Mogal H, Clarke CN, Christians KK, Tsai S, Gamblin T (2017). External radiation or ablation for solitary hepatocellular carcinoma: A survival analysis of the SEER database. Journal of surgical oncology, 116(3), 307-312.
  149. Silva JP, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, White S, Rilling W, Gamblin T (2017). Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis. HPB, 19(8), 659-666.
  150. Silva JP, Gorman RA, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin T (2017). The prognostic utility of baseline alpha-fetoprotein for hepatocellular carcinoma patients. Journal of surgical oncology, 116(7), 831-840.
  151. Buettner S, Galjart B, van Vugt JLA, Bagante F, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Margonis GA, Weiss M, Bauer TW, Shen F, Poultsides GA, Marsh JW, IJzermans JNM, Groot Koerkamp B, Pawlik T (2017). Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma. Journal of surgical oncology, 116(8), 1085-1095.
  152. Morris RS, Gani F, Hammad AY, Peltier W, Gamblin TC, Turaga KK, Johnston F (2017). Factors associated with palliative care use in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. The Journal of surgical research, 211, 79-86.
  153. Berger NG, Silva JP, Mogal H, Clarke CN, Bedi M, Charlson J, Christians KK, Tsai S, Gamblin T (2018). Overall survival after resection of retroperitoneal sarcoma at academic cancer centers versus community cancer centers: An analysis of the National Cancer Data Base. Surgery, 163(2), 318-323.
  154. Silva JP, Berger NG, Yin Z, Liu Y, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin T (2018). The effect of prior upper abdominal surgery on outcomes after liver transplantation for hepatocellular carcinoma: An analysis of the database of the organ procurement transplant network. Surgery, 163(5), 1028-1034.
  155. Berger NG, Herren JL, Liu C, Burrow RH, Silva JP, Tsai S, Christians KK, Gamblin T (2018). Ablation approach for primary liver tumors: Peri-operative outcomes. Journal of surgical oncology, 117(7), 1493-1499.
  156. Liu C, Berger NG, Rein L, Tarima S, Clarke C, Mogal H, Christians KK, Tsai S, Gamblin T (2018). Gallbladder carcinoma: An analysis of the national cancer data base to examine hispanic influence. Journal of surgical oncology, 117(8), 1664-1671.
  157. Johnson AC, Ethun CG, Liu Y, Lopez-Aguiar AG, Tran TB, Poultsides G, Grignol V, Howard JH, Bedi M, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Delman KA, Wood WC, Cardona K, Maithel S (2018). Studying a Rare Disease Using Multi-Institutional Research Collaborations vs Big Data: Where Lies the Truth?. Journal of the American College of Surgeons, 227(3), 357-366.e3.
  158. Buettner S, Spolverato G, Kimbrough CW, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Weiss M, Bauer TW, Shen F, Poultsides GA, Marsh JW, IJzermans JNM, Koerkamp BG, Pawlik T (2018). The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma. Surgery, 164(3), 411-418.
  159. Yu PY, Beal EW, Hughes TM, Suarez-Kelly LP, Shelby RD, Ethun CG, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard J (2018). Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma. The Journal of surgical research, 231, 248-256.
  160. Wilkinson KH, Ethun CG, Hembrook M, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Weber S, Gamblin TC, Cardona K, Clarke C (2019). Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative. The Journal of surgical research, 233, 154-162.
  161. Sherman SK, Lange JJ, Dahdaleh FS, Rajeev R, Gamblin TC, Polite BN, Turaga K (2019). Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer. JAMA oncology, 5(2), 236-242.
  162. Robbins JR, Schmid RK, Hammad AY, Gamblin TC, Erickson B (2019). Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival. Cancer medicine, 8(3), 928-938.
  163. Silva JP, Maurina MN, Tsai S, Christians KK, Clarke CN, Mogal H, Saeian K, Gamblin T (2019). Effect of Donor Race-Matching on Overall Survival for African-American Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Journal of the American College of Surgeons, 228(3), 245-254.
  164. Morgan Z, Chow BE, Strong EA, Tsai S, Christians K, Mogal H, Gamblin TC, Clarke C (2019). RAS Mutation Status Confers Prognostic Relevance in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer. The Journal of surgical research, 240, 130-135.
  165. Buettner S, Ten Cate DWG, Bagante F, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Margonis GA, Weiss M, Bauer TW, Shen F, Poultsides GA, Marsh JW, IJzermans JNM, Pawlik TM, Koerkamp B (2019). Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma. Journal of gastrointestinal surgery, 23(11), 2239-2246.
  166. Engelsgjerd S, Kunnimalaiyaan S, Kandil E, Gamblin TC, Kunnimalaiyaan (2019). Xanthohumol increases death receptor 5 expression and enhances apoptosis with the TNF-related apoptosis-inducing ligand in neuroblastoma cell lines. PloS one, 14(3), e0213776.
  167. Coon C, Berger N, Eastwood D, Tsai S, Christians K, Mogal H, Clarke C, Gamblin T (2020). Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy. Annals of surgical oncology, 27(4), 1156-1163.
  168. Gamboa AC, Ethun CG, Switchenko JM, Lipscomb J, Poultsides GA, Grignol V, Howard JH, Gamblin TC, Roggin KK, Votanopoulos K, Fields RC, Maithel SK, Delman KA, Cardona (2019). Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: Chest X-Ray or CT Scan?. Journal of the American College of Surgeons, 229(5), 449-457.
  169. Lee GC, Gamblin TC, Fong ZV, Ferrone CR, Goyal L, Lillemoe KD, Blaszkowsky LS, Tanabe KK, Qadan (2019). Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma. Annals of surgical oncology, 26(12), 4091-4099.
  170. Chouliaras K, Senehi R, Ethun CG, Poultsides G, Tran T, Grignol V, Gamblin TC, Roggin KK, Tseng J, Fields RC, Weber SM, Russell GB, Levine EA, Cardona K, Votanopoulos (2019). Recurrence patterns after resection of retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative. Journal of surgical oncology, 120(3), 340-347.
  171. Gamboa AC, Zaidi MY, Lee RM, Speegle S, Switchenko JM, Lipscomb J, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers BD, Lowy AM, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Lambert L, Hendrix RJ, Abbott DE, Vande Walle K, Lafaro K, Lee B, Johnston FM, Greer J, Russell MC, Staley CA, Maithel S (2020). Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative. Annals of surgical oncology, 27(1), 134-146.
  172. Squires MH, Ethun CG, Suarez-Kelly LP, Yu PY, Hughes TM, Shelby RD, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard J (2020). Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas. The Journal of surgical research, 245, 577-586.
  173. Zaidi MY, Lee RM, Gamboa AC, Speegle S, Cloyd JM, Kimbrough C, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Dessureault S, Kelly KJ, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Hendrix RJ, Lambert L, Ronnekleiv-Kelly S, Pokrzywa C, Blakely AM, Lee B, Johnston FM, Fackche N, Russell MC, Maithel SK, Staley CA 3r (2020). Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative. Annals of surgical oncology, 27(1), 156-164.
  174. Thalji SZ, Tsai S, Gamblin TC, Clarke C, Christians K, Charlson J, Ethun CG, Poultsides G, Grignol VP, Roggin KK, Votanopoulos K, Fields RC, Abbott DE, Cardona K, Mogal H, other members of the US Sarcoma Collaborativ (2020). Outcomes of palliative-intent surgery in retroperitoneal sarcoma-Results from the US Sarcoma Collaborative. Journal of surgical oncology, 121(7), 1140-1147.
  175. Strong EA, Park SH, Ethun CG, Chow B, King D, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Gamblin TC, Cardona K, Clarke C (2020). High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma. Surgery, 168(4), 760-767.
  176. Liu C, Rein L, Clarke C, Mogal H, Tsai S, Christians KK, Gamblin T (2020). Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base. Journal of surgical oncology, 122(2), 176-182.
  177. Chavez MI, Gholami S, Kim BJ, Margonis GA, Ethun CG, Tsai S, Christians KK, Clarke C, Mogal H, Maithel SK, Pawlik TM, D'Angelica MI, Aloia TA, Eastwood D, Gamblin T (2021). Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis. Annals of surgical oncology, 28(3), 1457-1465.
  178. Lee RM, Ethun CG, Zaidi MY, Tran TB, Poultsides GA, Grignol VP, Howard JH, Bedi M, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Oskouei SV, Monson DK, Reimer NB, Maithel SK, Cardona (2020). A closer look at the natural history and recurrence patterns of high-grade truncal/extremity leiomyosarcomas: A multi-institutional analysis from the US Sarcoma Collaborative. Surgical oncology, 34, 292-297.
  179. Chouliaras K, Patel N, Senehi R, Ethun CG, Poultsides G, Grignol V, Gamblin TC, Roggin KK, Fields RC, D'Agostino R Jr, Levine EA, Cardona K, Votanopoulos (2021). Impact of resection margin on outcomes in high-grade soft tissue sarcomas of the extremity-A USSC analysis. Journal of surgical oncology, 123(2), 479-488.
  180. Fackche N, Schmocker RK, Kubi B, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Powers B, Dineen S, Veerapong J, Baumgartner JM, Clarke C, Gamblin TC, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Zaidi MY, Maithel SK, Johnston FM, Greer J (2021). The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative. Journal of gastrointestinal surgery, 25(11), 2908-2919.
  181. Franssen S, Soares KC, Jolissaint JS, Tsilimigras DI, Buettner S, Alexandrescu S, Marques H, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Margonis GA, Weiss MJ, Bauer TW, Shen F, Poultsides GA, Marsh JW, Cercek A, Kemeny N, Kingham TP, D'Angelica M, Pawlik TM, Jarnagin WR, Koerkamp B (2022). Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma. JAMA surgery, 157(7), 590-596.
  182. Strong EA, Livingston A, Gracz M, Peltier W, Tsai S, Christians K, Gamblin TC, Kersting K, Clarke C (2022). Palliative Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis: Is It Safe and Effective?. The Journal of surgical research, 278, 31-38.
  183. Chrabaszcz S, Rajeev R, Witmer HDD, Dhiman A, Klooster B, Gamblin TC, Banerjee A, Johnston FM, Turaga K (2022). A Systematic Review of Conversion to Resectability in Unresectable Metastatic Colorectal Cancer Chemotherapy Trials. American journal of clinical oncology, 45(8), 366-372.
  184. Thalji SZ, Ethun CG, Tsai S, Gamblin TC, Clarke CN, Bedi M, King D, LoGiudice J, Poultsides G, Grignol VP, Tseng J, Votanopoulos K, Fields RC, Cardona K, Mogal (2023). Outcomes of plastic surgical reconstruction in extremity and truncal soft tissue sarcoma: Results from the US Sarcoma Collaborative. Journal of surgical oncology, 127(4), 550-559.
  185. Merrill JR, Flitcroft MA, Miller T, Beichner B, Clarke CN, Maduekwe UN, Wang TS, Dream S, Christians KK, Gamblin TC, Evans DB, Kothari A (2023). Patterns of Unnecessary Insurer Prior Authorization Denials in a Complex Surgical Oncology Practice. The Journal of surgical research, 288, 269-274.
  186. Servin-Rojas M, Shafique N, Sell NM, Gamblin TC, Qadan (2023). Facility type is associated with improved perioperative and oncologic outcomes after minimally invasive surgery for pancreatic cancer. HPB, 25(8), 933-940.
  187. SenthilKumar G, Madhusudhana S, Flitcroft M, Sheriff S, Thalji S, Merrill J, Clarke CN, Maduekwe UN, Tsai S, Christians KK, Gamblin TC, Kothari A (2023). Automated machine learning (AutoML) can predict 90-day mortality after gastrectomy for cancer. Scientific reports, 13(1), 11051.
  188. Silva JP, Berger NG, Yin Z, Liu Y, Tsai S, Christians KK, Clarke CN, Mogal H, Clark Gamblin (2018). Minimally invasive hepatectomy conversions: an analysis of risk factors and outcomes. HPB, 20(2), 132-139.
  189. Sekigami Y, Rajeev R, Johnston F, Clark Gamblin T, Turaga K (2016). Conditional Survival as a Patient Centered Metric for Patients with Appendiceal Adenocarcinoma. Annals of surgical oncology, 23(7), 2295-301.
  190. Marcus RK, Geurts JL, Grzybowski JA, Turaga KK, Clark Gamblin T, Strong KA, Johnston F (2015). Challenges to clinical utilization of hereditary cancer gene panel testing: perspectives from the front lines. Familial cancer, 14(4), 641-9.
  191. Spolverato G, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Clark Gamblin T, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Tran TB, Wallis Marsh J, Pawlik T (2016). Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection. Annals of surgical oncology, 23(1), 235-43.
  192. Kashtan MA, Jayakrishnan TT, Rajeev R, Charlson JC, Johnston F, Clark Gamblin T, Turaga K (2016). Age-based disparities in treatment and outcomes of retroperitoneal rhabdomyosarcoma. International journal of clinical oncology, 21(3), 602-8.
  193. Miura JT, Johnston FM, Tsai S, George B, Thomas J, Eastwood D, Banerjee A, Christians KK, Turaga KK, Pawlik TM, Clark Gamblin (2015). Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma. Annals of surgical oncology, 22(11), 3716-23.
  194. Spolverato G, Kim Y, Alexandrescu S, Popescu I, Marques HP, Aldrighetti L, Clark Gamblin T, Miura J, Maithel SK, Squires MH, Pulitano C, Sandroussi C, Mentha G, Bauer TW, Newhook T, Shen F, Poultsides GA, Wallis Marsh J, Pawlik T (2015). Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration. Annals of surgical oncology, 22(7), 2218-25.
  195. O'Rorke M, Chrischilles E, NET'PRO Study Investigator (2024). Making progress against rare cancers: A case study on neuroendocrine tumors. Cancer, 130(9), 1568-1574.
  196. Chicago Consensus Working Grou (2020). The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors. Annals of surgical oncology, 27(6), 1793-1797.
  197. Chicago Consensus Working Grou (2020). The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms. Annals of surgical oncology, 27(6), 1780-1787.
  198. Chicago Consensus Working Grou (2020). The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases. Annals of surgical oncology, 27(6), 1768-1773.
  199. Chicago Consensus Working Grou (2020). The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations. Annals of surgical oncology, 27(6), 1798-1804.
  200. Chicago Consensus Working Grou (2020). The Chicago Consensus on Peritoneal Surface Malignancies: Standards. Annals of surgical oncology, 27(6), 1743-1752.
  201. Chicago Consensus Working Grou (2020). The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasms. Cancer, 126(11), 2525-2533.
  202. Engelsgjerd S, Kunnimalaiyaan S, Kandil E, Gamblin TC, Kunnimalaiyaan (2019). Xanthohumol increases death receptor 5 expression and enhances apoptosis with the TNF-related apoptosis-inducing ligand in neuroblastoma cell lines. PloS one, 14(3), e0213776.
  203. Shivakumar N, Hammad AY, Gamblin T (2016). Frank Netter: A Man of Art and Science. The American surgeon, 82(5), 377-9.
  204. Bischof DA, Dodson R, Jimenez MC, Behman R, Cocieru A, Blazer DG 3rd, Fisher SB, Squires MH 3rd, Kooby DA, Maithel SK, Groeschl RT, Gamblin TC, Bauer TW, Karanicolas PJ, Law C, Quereshy FA, Pawlik T (2015). Adherence to Guidelines for Adjuvant Imatinib Therapy for GIST: A Multi-institutional Analysis. Journal of gastrointestinal surgery, 19(6), 1022-8.
  205. Amini A, Miura JT, Larrieux G, Tsai S, Turaga KK, Christians KK, Brasel KJ, Clark Gamblin T, Weissman DE, Nattinger AB, Johnston F (2015). Palliative care training in surgical oncology and hepatobiliary fellowships: a national survey of the fellows. Annals of surgical oncology, 22(6), 1761-7.
  206. Hammond JS, Franko J, Holloway SE, Heckman JT, Orons PD, Gamblin T (2014). Gemcitabine transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma. Hepato-gastroenterology, 61(133), 1339-43.

Review

  1. Gamblin TC, Stephens RE Jr, Johnson RK, Rothwell M (2003). Adult malrotation: a case report and review of the literature. [Review]. Curr Surg, 60, (5), 517-20.
  2. Gamblin TC, Glenn J, Herring D, McKinney WB (2003). Bowel obstruction caused by a Meckel's diverticulum enterolith: a case report and review of the literature. [Review]. Curr Surg, 60, (1), 63-4.
  3. Gusani NJ, Marsh JW, Nalesnik MA, Tublin ME, Gamblin TC (2008). Carcinoid of the extra-hepatic bile duct: a case report with long-term follow-up and review of literature. [Review]. Am Surg, 74, (1), 87-90.
  4. Nguyen KT, Gamblin TC, Geller D (2008). Laparoscopic liver resection for cancer. Future oncology (London, England), 4(5), 661-70.
  5. Amesur N, Hammond JS, Zajko AB, Geller DA, Gamblin T (2009). Management of unresectable symptomatic focal nodular hyperplasia with arterial embolization. Journal of vascular and interventional radiology, 20(4), 543-7.
  6. Nguyen KT, Gamblin TC, Geller D (2009). World review of laparoscopic liver resection-2,804 patients. Annals of surgery, 250(5), 831-41.
  7. Parent BA, Cho SW, Buck DG, Nalesnik MA, Gamblin T (2010). Spontaneous rupture of hepatic artery aneurysm associated with polyarteritis nodosa. The American surgeon, 76(12), 1416-9.
  8. Nguyen KT, Marsh JW, Tsung A, Steel JJ, Gamblin TC, Geller D (2011). Comparative benefits of laparoscopic vs open hepatic resection: a critical appraisal. Archives of surgery (Chicago, Ill., 146(3), 348-56.
  9. Pilgrim CH, Groeschl RT, Pappas SG, Gamblin T (2013). An often overlooked diagnosis: imaging features of gallbladder cancer. Journal of the American College of Surgeons, 216(2), 333-9.
  10. Caldow Pilgrim CH, Groeschl RT, Quebbeman EJ, Gamblin T (2013). Recent advances in systemic therapies and radiotherapy for gallbladder cancer. Surgical oncology, 22(1), 61-7.
  11. Pilgrim CH, Groeschl RT, Christians KK, Gamblin T (2013). Modern perspectives on factors predisposing to the development of gallbladder cancer. HPB, 15(11), 839-44.
  12. Pilgrim CH, Groeschl RT, Turaga KK, Gamblin T (2013). Key factors influencing prognosis in relation to gallbladder cancer. Digestive diseases and sciences, 58(9), 2455-62.
  13. Maithel SK, Gamblin TC, Kamel I, Corona-Villalobos CP, Thomas M, Pawlik T (2013). Multidisciplinary approaches to intrahepatic cholangiocarcinoma. Cancer, 119(22), 3929-42.
  14. Jayakrishnan TT, Groeschl RT, George B, Thomas JP, Clark Gamblin T, Turaga K (2014). Review of the impact of antineoplastic therapies on the risk for cholelithiasis and acute cholecystitis. Annals of surgical oncology, 21(1), 240-7.
  15. Jayakrishnan TT, Groeschl RT, George B, Thomas JP, Pappas S, Gamblin TC, Turaga K (2014). Management of acute cholecystitis in cancer patients: a comparative effectiveness approach. Surgical endoscopy, 28(5), 1505-14.
  16. Hwang M, Jayakrishnan TT, Green DE, George B, Thomas JP, Groeschl RT, Erickson B, Pappas SG, Gamblin TC, Turaga K (2014). Systematic review of outcomes of patients undergoing resection for colorectal liver metastases in the setting of extra hepatic disease. European journal of cancer (Oxford, England, 50(10), 1747-1757.
  17. North DA, Groeschl RT, Sindram D, Martinie JB, Iannitti DA, Bloomston M, Schmidt C, Rilling WS, Gamblin TC, Martin R (2014). Microwave ablation for hepatic malignancies: a call for standard reporting and outcomes. American journal of surgery, 208(2), 284-94.
  18. Shariat-Madar B, Jayakrishnan TT, Gamblin TC, Turaga K (2014). Surgical management of bowel obstruction in patients with peritoneal carcinomatosis. Journal of surgical oncology, 110(6), 666-9.
  19. Helm JH, Miura JT, Glenn JA, Marcus RK, Larrieux G, Jayakrishnan TT, Donahue AE, Gamblin TC, Turaga KK, Johnston F (2015). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Annals of surgical oncology, 22(5), 1686-93.
  20. Boehm LM, Jayakrishnan TT, Miura JT, Zacharias AJ, Johnston FM, Turaga KK, Gamblin T (2015). Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma. Journal of surgical oncology, 111(2), 213-20.
  21. Celinski SA, Gamblin T (2010). Hepatic resection nomenclature and techniques. The Surgical clinics of North America, 90(4), 737-48.
  22. Gamblin TC, Christians K, Pappas S (2011). Radiofrequency ablation of neuroendocrine hepatic metastasis. Surgical oncology clinics of North America, 20(2), 273-9, vii-viii.
  23. Rajeev R, Gamblin TC, Turaga K (2016). Hepatic Perfusion Therapy. The Surgical clinics of North America, 96(2), 357-68.
  24. Tsai S, Gamblin T (2019). Molecular Characteristics of Biliary Tract and Primary Liver Tumors. Surgical oncology clinics of North America, 28(4), 685-693.
  25. Miura JT, Gamblin T (2015). Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis. Surgical oncology clinics of North America, 24(1), 149-66.
  26. Koprowski S, Sokolowski K, Kunnimalaiyaan S, Gamblin TC, Kunnimalaiyaan (2015). Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma. The Journal of surgical research, 198(2), 434-40.
  27. Sokolowski KM, Koprowski S, Kunnimalaiyaan S, Balamurugan M, Gamblin TC, Kunnimalaiyaan (2016). Potential Molecular Targeted Therapeutics: Role of PI3-K/Akt/mTOR Inhibition in Cancer. Anti-cancer agents in medicinal chemistry, 16(1), 29-37.
  28. Cheng H, Miura JT, Lalehzari M, Rajeev R, Donahue AE, Bedi M, Gamblin TC, Turaga KK, Johnston F (2016). Neoadjuvant radiotherapy for retroperitoneal sarcoma: A systematic review. Journal of surgical oncology, 113(6), 628-34.
  29. Hammad AY, Miura JT, Turaga KK, Johnston FM, Hohenwalter MD, Gamblin T (2016). A literature review of radiological findings to guide the diagnosis of gallbladder adenomyomatosis. HPB, 18(2), 129-135.
  30. Bliss LA, Strong EA, Gamblin T (2019). Surgical resectability of multisite metastatic colorectal cancer: Pushing the limits while appropriately selecting patients. Journal of surgical oncology, 119(5), 623-628.
  31. Baker T, Tabrizian P, Zendejas I, Gamblin TC, Kazimi M, Boudjema K, Geller D, Salem (2022). Conversion to resection post radioembolization in patients with HCC: recommendations from a multidisciplinary working group. HPB, 24(7), 1007-1018.
  32. Lundberg RK, Elftmann AE, Wilson SD, Gamblin T (2023). The Connell Stitch: A Two-Generation Contribution to Gastrointestinal Surgery. The American surgeon, 89(12), 6449-6451.
  33. Gamboa AC, Kooby DA, Maithel SK, Gamblin T (2024). Immune checkpoint inhibitors in hepatocellular carcinoma: A review of current clinical trials. Journal of surgical oncology, 129(1), 63-70.

Editorial

  1. Gamblin TC, Geller DA (2005). Downstaging hepatocellular carcinoma prior to liver transplantation. Liver Transpl, 11(12), 1466-8.
  2. Gamblin TC, Wall CE Jr, Royer GM, Dalton ML, Ashley DW (2005). Delayed splenic rupture: case reports and review of the literature. J Trauma, 59(5), 1231-4.
  3. Geller DA, Tsung A, Marsh JW, Dvorchik I, Gamblin TC, Carr BI (2006). Outcome of 1000 liver cancer patients evaluated at the UPMC Liver Cancer Center. J Gastrointest Surg, 10(1), 63-8.
  4. Gamblin TC, Santos RS, Baratz M, Landreneau RJ (2006). Metastatic colon cancer to the hand. Am Surg, 72(1), 98-100.
  5. Gamblin T, Alexander H, Edwards R, Bartlett D (2012). Concepts of regional therapies for advanced malignancy. Annals of surgical oncology, 19(5), 1371-2.
  6. Gamblin TC, Alexander HR, Edwards R, Bartlett D (2013). Regional therapies for cancer. Annals of surgical oncology, 20(4), 1053-5.
  7. Gamblin T (2019). Hepatobiliary Malignancies: The Changing Landscape. Surgical oncology clinics of North America, 28(4), xv.
  8. Turaga KK, Gamblin TC, Alexander HR, Edwards R, Bartlett D (2016). Regional Therapies for Advanced Cancer: Update for 2016. Annals of surgical oncology, 23(5), 1452-3.
  9. Bagante F, Gamblin TC, Pawlik T (2016). Cholangiocarcinoma risk factors and the potential role of aspirin. Hepatology (Baltimore, Md.), 64(3), 708-10.
  10. Turaga KK, Gamblin TC, Edwards R, Alexander HR, Bartlett (2019). It Is Time. Annals of surgical oncology, 26(7), 1963-1966.
  11. Turaga KK, Clark Gamblin T, Richard Alexander H, Edwards R, Bartlett D (2018). Together We Make a Difference. Annals of surgical oncology, 25(7), 1794-1796.
  12. Turaga KK, Clark Gamblin T, Edwards R, Richard Alexander H, Bartlett D (2017). Ushering in a New Era for Regional Therapies. Annals of surgical oncology, 24(4), 868-869.
  13. Turaga KK, Clark Gamblin T, Richard Alexander H, Edwards R, Bartlett D (2015). Moving fast and moving slow. Annals of surgical oncology, 22(5), 1631-3.
  14. Gamblin T (2019). Hepatobiliary Malignancies: The Changing Landscape. Surgical oncology clinics of North America, 28(4), xv.

News & Podcasts

Huntsman Cancer Institute News